Literature DB >> 20194747

Dose-dependent induction of distinct phenotypic responses to Notch pathway activation in mammary epithelial cells.

Marco Mazzone1, Laura M Selfors, John Albeck, Michael Overholtzer, Sanja Sale, Danielle L Carroll, Darshan Pandya, Yiling Lu, Gordon B Mills, Jon C Aster, Spyros Artavanis-Tsakonas, Joan S Brugge.   

Abstract

Aberrant activation of Notch receptors has been implicated in breast cancer; however, the mechanisms contributing to Notch-dependent transformation remain elusive because Notch displays dichotomous functional activities, promoting both proliferation and growth arrest. We investigated the cellular basis for the heterogeneous responses to Notch pathway activation in 3D cultures of MCF-10A mammary epithelial cells. Expression of a constitutively active Notch-1 intracellular domain (NICD) was found to induce two distinct types of 3D structures: large, hyperproliferative structures and small, growth-arrested structures with reduced cell-to-matrix adhesion. Interestingly, we found that these heterogeneous phenotypes reflect differences in Notch pathway activation levels; high Notch activity caused down-regulation of multiple matrix-adhesion genes and inhibition of proliferation, whereas low Notch activity maintained matrix adhesion and provoked a strong hyperproliferative response. Moreover, microarray analyses implicated NICD-induced p63 down-regulation in loss of matrix adhesion. In addition, a reverse-phase protein array-based analysis and subsequent loss-of-function studies identified STAT3 as a dominant downstream mediator of the NICD-induced outgrowth. These results indicate that the phenotypic responses to Notch are determined by the dose of pathway activation; and this dose affects the balance between growth-stimulative and growth-suppressive effects. This unique feature of Notch signaling provides insights into mechanisms that contribute to the dichotomous effects of Notch during development and tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20194747      PMCID: PMC2841923          DOI: 10.1073/pnas.1000896107

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  39 in total

1.  The role of apoptosis in creating and maintaining luminal space within normal and oncogene-expressing mammary acini.

Authors:  Jayanta Debnath; Kenna R Mills; Nicole L Collins; Mauricio J Reginato; Senthil K Muthuswamy; Joan S Brugge
Journal:  Cell       Date:  2002-10-04       Impact factor: 41.582

2.  Hes binding to STAT3 mediates crosstalk between Notch and JAK-STAT signalling.

Authors:  Sachiko Kamakura; Koji Oishi; Takeshi Yoshimatsu; Masato Nakafuku; Norihisa Masuyama; Yukiko Gotoh
Journal:  Nat Cell Biol       Date:  2004-05-23       Impact factor: 28.824

3.  Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia.

Authors:  Andrew P Weng; Adolfo A Ferrando; Woojoong Lee; John P Morris; Lewis B Silverman; Cheryll Sanchez-Irizarry; Stephen C Blacklow; A Thomas Look; Jon C Aster
Journal:  Science       Date:  2004-10-08       Impact factor: 47.728

4.  Notch signaling is a direct determinant of keratinocyte growth arrest and entry into differentiation.

Authors:  A Rangarajan; C Talora; R Okuyama; M Nicolas; C Mammucari; H Oh; J C Aster; S Krishna; D Metzger; P Chambon; L Miele; M Aguet; F Radtke; G P Dotto
Journal:  EMBO J       Date:  2001-07-02       Impact factor: 11.598

5.  Integrins and EGFR coordinately regulate the pro-apoptotic protein Bim to prevent anoikis.

Authors:  Mauricio J Reginato; Kenna R Mills; Jessica K Paulus; Danielle K Lynch; Dennis C Sgroi; Jayanta Debnath; Senthil K Muthuswamy; Joan S Brugge
Journal:  Nat Cell Biol       Date:  2003-08       Impact factor: 28.824

6.  Modulation of notch signaling elicits signature tumors and inhibits hras1-induced oncogenesis in the mouse mammary epithelium.

Authors:  Hippokratis Kiaris; Katerina Politi; Lisa M Grimm; Matthias Szabolcs; Peter Fisher; Argiris Efstratiadis; Spyros Artavanis-Tsakonas
Journal:  Am J Pathol       Date:  2004-08       Impact factor: 4.307

Review 7.  The role of Notch in tumorigenesis: oncogene or tumour suppressor?

Authors:  Freddy Radtke; Kenneth Raj
Journal:  Nat Rev Cancer       Date:  2003-10       Impact factor: 60.716

8.  Ectopic expression of the Drosophila Cdk1 inhibitory kinases, Wee1 and Myt1, interferes with the second mitotic wave and disrupts pattern formation during eye development.

Authors:  Donald M Price; Zhigang Jin; Simon Rabinovitch; Shelagh D Campbell
Journal:  Genetics       Date:  2002-06       Impact factor: 4.562

9.  Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers.

Authors:  Elgene Lim; François Vaillant; Di Wu; Natasha C Forrest; Bhupinder Pal; Adam H Hart; Marie-Liesse Asselin-Labat; David E Gyorki; Teresa Ward; Audrey Partanen; Frank Feleppa; Lily I Huschtscha; Heather J Thorne; Stephen B Fox; Max Yan; Juliet D French; Melissa A Brown; Gordon K Smyth; Jane E Visvader; Geoffrey J Lindeman
Journal:  Nat Med       Date:  2009-08-02       Impact factor: 53.440

10.  Notch1 can contribute to viral-induced transformation of primary human keratinocytes.

Authors:  Stéphanie Lathion; Janina Schaper; Peter Beard; Kenneth Raj
Journal:  Cancer Res       Date:  2003-12-15       Impact factor: 12.701

View more
  94 in total

1.  Altered differentiation and paracrine stimulation of mammary epithelial cell proliferation by conditionally activated Smoothened.

Authors:  Adriana P Visbal; Heather L LaMarca; Hugo Villanueva; Michael J Toneff; Yi Li; Jeffrey M Rosen; Michael T Lewis
Journal:  Dev Biol       Date:  2011-01-27       Impact factor: 3.582

Review 2.  Notch and disease: a growing field.

Authors:  Angeliki Louvi; Spyros Artavanis-Tsakonas
Journal:  Semin Cell Dev Biol       Date:  2012-02-20       Impact factor: 7.727

Review 3.  The double-edged sword of Notch signaling in cancer.

Authors:  Andrew P South; Raymond J Cho; Jon C Aster
Journal:  Semin Cell Dev Biol       Date:  2012-01-30       Impact factor: 7.727

4.  Heterogeneously expressed fezf2 patterns gradient Notch activity in balancing the quiescence, proliferation, and differentiation of adult neural stem cells.

Authors:  Michael A Berberoglu; Zhiqiang Dong; Guangnan Li; Jiashun Zheng; Luz del Carmen G Trejo Martinez; Jisong Peng; Mahendra Wagle; Brian Reichholf; Claudia Petritsch; Hao Li; Samuel J Pleasure; Su Guo
Journal:  J Neurosci       Date:  2014-10-15       Impact factor: 6.167

Review 5.  Signal transduction in cancer.

Authors:  Richard Sever; Joan S Brugge
Journal:  Cold Spring Harb Perspect Med       Date:  2015-04-01       Impact factor: 6.915

Review 6.  Reverse phase protein microarrays advance to use in clinical trials.

Authors:  Claudius Mueller; Lance A Liotta; Virginia Espina
Journal:  Mol Oncol       Date:  2010-10-16       Impact factor: 6.603

Review 7.  Receptor tyrosine kinases in the nucleus.

Authors:  Graham Carpenter; Hong-Jun Liao
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-10-01       Impact factor: 10.005

8.  NOTCH1 activation in breast cancer confers sensitivity to inhibition of SUMOylation.

Authors:  M P Licciardello; M K Müllner; G Dürnberger; C Kerzendorfer; B Boidol; C Trefzer; S Sdelci; T Berg; T Penz; M Schuster; C Bock; R Kralovics; G Superti-Furga; J Colinge; S M Nijman; S Kubicek
Journal:  Oncogene       Date:  2014-09-29       Impact factor: 9.867

9.  Realizing the promise of reverse phase protein arrays for clinical, translational, and basic research: a workshop report: the RPPA (Reverse Phase Protein Array) society.

Authors:  Rehan Akbani; Karl-Friedrich Becker; Neil Carragher; Ted Goldstein; Leanne de Koning; Ulrike Korf; Lance Liotta; Gordon B Mills; Satoshi S Nishizuka; Michael Pawlak; Emanuel F Petricoin; Harvey B Pollard; Bryan Serrels; Jingchun Zhu
Journal:  Mol Cell Proteomics       Date:  2014-04-28       Impact factor: 5.911

10.  Loss of Notch1-dependent p21(Waf1/Cip1) expression influences the Notch1 outcome in tumorigenesis.

Authors:  Samantha Cialfi; Rocco Palermo; Sonia Manca; Carlo De Blasio; Paula Vargas Romero; Saula Checquolo; Diana Bellavia; Daniela Uccelletti; Michele Saliola; Angelo D'Alessandro; Lello Zolla; Alberto Gulino; Isabella Screpanti; Claudio Talora
Journal:  Cell Cycle       Date:  2014-05-06       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.